{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:00:16Z","timestamp":1787317216563,"version":"build-2736575974"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ocugen, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41433-025-04202-5","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:19:41Z","timestamp":1768036781000},"page":"429-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8928-5599","authenticated-orcid":false,"given":"Arshad M.","family":"Khanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Vajzovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bakall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Ramana Murthy","family":"Chavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"4202_CR1","doi-asserted-by":"crossref","unstructured":"Mata NL, Weng S, Michaelides M, Charbel Issa P, Quinodoz M, Rivolta C, et al. Bisretinoids as a source of early photoreceptor pathology in Stargardt disease. Ophthalmic Res. 2025;68:555\u201372.","DOI":"10.1159\/000549368"},{"key":"4202_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/bjophthalmol-2018-312064","volume":"103","author":"K Fujinami","year":"2019","unstructured":"Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, et al. Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. Br J Ophthalmol. 2019;103:390\u20137.","journal-title":"Br J Ophthalmol"},{"key":"4202_CR3","doi-asserted-by":"publisher","unstructured":"Pas JAAH, Dhooge PPA, Li CHZ, Collin RWJ, Hoyng CB, IntHout J. Randomizing eyes or patients in clinical trials for Stargardt disease. Ophthalmol Sci. https:\/\/doi.org\/10.1016\/j.xops.2025.101021.","DOI":"10.1016\/j.xops.2025.101021"},{"key":"4202_CR4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.ophtha.2017.04.026","volume":"124","author":"X Kong","year":"2017","unstructured":"Kong X, Strauss RW, Cideciyan AV, Michaelides M, Sahel JA, Munoz B, et al. Visual acuity change over 12 months in the prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar report number 6. Ophthalmology. 2017;124:1640\u201351.","journal-title":"Ophthalmology"},{"key":"4202_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/jamaophthalmol.2018.2198","volume":"136","author":"X Kong","year":"2018","unstructured":"Kong X, Fujinami K, Strauss RW, Munoz B, West SK, Cideciyan AV, et al. Visual acuity change over 24 months and its association with foveal phenotype and genotype in individuals with Stargardt disease: ProgStar study report no. 10. JAMA Ophthalmol. 2018;136:920\u20138.","journal-title":"JAMA Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04202-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:06:44Z","timestamp":1770372404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04202-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4202"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04202-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}